Theranexus, an innovative biopharmaceutical company that came through IncubAlliance, announced that it has obtained €6.2 million in financing as part of the Investments for the Future program (PIA) operated by Bpifrance (a Structuring Research and Development Project for Competitiveness, PSPC) to develop the Neurolead program.